AlphaRx Positions Itself For Future Growth With Their Proprietary Drug Delivery Technology.Business Editors & Health/Medical Writers RICHMOND HILL, Ontario--(BW HealthWire)--March 22, 2002 AlphaRx Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :ALRX) is re-positioning itself to capitalize on opportunities presented within the pharmaceutical industry as specialists in drug delivery technology. "The extremely poor market conditions during the last twelve months temporarily hindered our anticipated private placement, (as announced in July, 2001) slowing down our sales and marketing expectations," explained Michael Lee, President & CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of AlphaRx. "Through our recent stock consolidation, the introduction of our online sales strategy and continued focus on product development, management is taking proactive steps to increase the operational efficiency and performance of the Company." AlphaRx is now able to generate revenue from the sale of four over-the-counter products on the market, namely: ARX 100C -- the Company's oral health product, COQ10ER -- a once-a-day heart health product and its two topical Flexogan creams for arthritis pain and muscle pain relief. As specialists in drug delivery technology, AlphaRx continues to develop its product pipeline and intends to solidify strategic partnerships and out-licensing opportunities with large pharmaceutical companies to continue the development and commercialisation process. The Company is also exploring potential acquisitions as part of its growth strategy for the future. About AlphaRx AlphaRx is an emerging pharmaceutical company that develops and markets innovative therapeutic products based on its proprietary Bioadhesive Colloidal colloidal of the nature of a colloid. colloidal bath a bath containing gelatin, bran, starch or similar substances, to relieve skin irritation and pruritus. Dispersion (BCD (Binary Coded Decimal) The storage of numbers in which each decimal digit is converted into binary and is stored in a single character or byte. For example, a 12-digit number would take 12 bytes. See binary numbers. ) drug delivery technology. AlphaRx's BCD technology improves the bioavailability bioavailability /bio·avail·a·bil·i·ty/ (bi?o-ah-val?ah-bil´i-te) the degree to which a drug or other substance becomes available to the target tissue after administration. bi·o·a·vail·a·bil·i·ty n. and bioperformance of poorly water-soluble drugs to provide enhanced medical benefits and competitive commercial advantages. FORWARD LOOKING STATEMENTS This release contains forward-looking statements within the meaning and pursuant to the Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. provisions of the Securities Litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. Reform Act of 1995 and involve risks and uncertainties that may individually or mutually impact the matters herein described, including but not limited to product development and acceptance, manufacturing, competition, regulatory and/or other factors, which are outside the control of the Company. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion